At 24 months after the end of treatment , the adjusted difference in the risk of an unfavorable outcome ( experimental group [ 21.0 % ] minus control group [ 17.2 % ] ) in the modified intention-to-treat population ( 1356 patients ) was 3.5 percentage points ( 95 % confidence interval , -0.7 to 7.7 ) .